Evaluating the role of common risk variation in the recurrence risk of schizophrenia in multiplex schizophrenia families
- PMID: 35864105
- PMCID: PMC9304393
- DOI: 10.1038/s41398-022-02060-3
Evaluating the role of common risk variation in the recurrence risk of schizophrenia in multiplex schizophrenia families
Abstract
Multiplex families have higher recurrence risk of schizophrenia compared to the families of sporadic cases, but the source of this increased recurrence risk is unknown. We used schizophrenia genome-wide association study data (N = 156,509) to construct polygenic risk scores (PRS) in 1005 individuals from 257 multiplex schizophrenia families, 2114 ancestry-matched sporadic cases, and 2205 population controls, to evaluate whether increased PRS can explain the higher recurrence risk of schizophrenia in multiplex families compared to ancestry-matched sporadic cases. Using mixed-effects logistic regression with family structure modeled as a random effect, we show that SCZ PRS in familial cases does not differ significantly from sporadic cases either with, or without family history (FH) of psychotic disorders (All sporadic cases p = 0.90, FH+ cases p = 0.88, FH- cases p = 0.82). These results indicate that increased burden of common schizophrenia risk variation as indexed by current SCZ PRS, is unlikely to account for the higher recurrence risk of schizophrenia in multiplex families. In the absence of elevated PRS, segregation of rare risk variation or environmental influences unique to the families may explain the increased familial recurrence risk. These findings also further validate a genetically influenced psychosis spectrum, as shown by a continuous increase of common SCZ risk variation burden from unaffected relatives to schizophrenia cases in multiplex families. Finally, these results suggest that common risk variation loading are unlikely to be predictive of schizophrenia recurrence risk in the families of index probands, and additional components of genetic risk must be identified and included in order to improve recurrence risk prediction.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia.Br J Psychiatry. 2023 Jul;223(1):301-308. doi: 10.1192/bjp.2022.179. Br J Psychiatry. 2023. PMID: 36503694 Free PMC article.
-
Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum.Epidemiol Psychiatr Sci. 2020 Nov 17;29:e182. doi: 10.1017/S2045796020000943. Epidemiol Psychiatr Sci. 2020. PMID: 33200977 Free PMC article.
-
Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia.JAMA Psychiatry. 2023 Feb 1;80(2):181-185. doi: 10.1001/jamapsychiatry.2022.4234. JAMA Psychiatry. 2023. PMID: 36542388 Free PMC article.
-
Molecular genetic studies of schizophrenia: challenges and insights.Neurosci Res. 2002 Aug;43(4):295-304. doi: 10.1016/s0168-0102(02)00064-0. Neurosci Res. 2002. PMID: 12135773 Review.
-
Polygenic risk for schizophrenia and associated brain structural changes: A systematic review.Compr Psychiatry. 2019 Jan;88:77-82. doi: 10.1016/j.comppsych.2018.11.014. Epub 2018 Nov 29. Compr Psychiatry. 2019. PMID: 30529765
Cited by
-
Investigating the role of common and rare variants in multiplex multiple sclerosis families reveals an increased burden of common risk variation.Sci Rep. 2022 Oct 10;12(1):16984. doi: 10.1038/s41598-022-21484-x. Sci Rep. 2022. PMID: 36216875 Free PMC article.
-
Examining the source of increased bipolar disorder and major depressive disorder common risk variation burden in multiplex schizophrenia families.Schizophrenia (Heidelb). 2022 Nov 25;8(1):106. doi: 10.1038/s41537-022-00317-w. Schizophrenia (Heidelb). 2022. PMID: 36434002 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
- R01 MH062276/MH/NIMH NIH HHS/United States
- R01 MH083094/MH/NIMH NIH HHS/United States
- K25 AA030072/AA/NIAAA NIH HHS/United States
- 090532/Z/09/Z /WT_/Wellcome Trust/United Kingdom
- R01 MH068881/MH/NIMH NIH HHS/United States
- 075491/Z/04/B/WT_/Wellcome Trust/United Kingdom
- 072894/Z/03/Z/WT_/Wellcome Trust/United Kingdom
- T32-MH020030/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- 085475/Z/08/Z/WT_/Wellcome Trust/United Kingdom
- R01-MH114593/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- 085475/B/08/Z/WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous